CONCLUSION: In elderly patients with chronic HCV, IFN for a subgroup with intermediate and low platelet counts had significant advantages in regard to hepatocarcinogenesis and survival.

• 结论：在老年慢性丙肝患者中，在中等或低血小板患者中进行干扰素治疗对于癌发生和生存率有显著优势。